Pharmacologic treatment of depression during pregnancy.
- 6 October 1999
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 282 (13) , 1264-1269
- https://doi.org/10.1001/jama.282.13.1264
Abstract
Despite the frequency of depression in women of childbearing age, information to guide patients and physicians through a consideration of treatment during pregnancy is limited.Keywords
This publication has 24 references indexed in Scilit:
- Psychobiology of Postpartum Mood DisordersSeminars in Reproductive Medicine, 1997
- Neurodevelopment of Children Exposed in Utero to Antidepressant DrugsNew England Journal of Medicine, 1997
- Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitorsInternational Clinical Psychopharmacology, 1996
- Suspected congenital sertraline dependenceThe British Journal of Psychiatry, 1995
- Psychobiological Influences of Stress and HPA Regulation on the Human Fetus and Infant Birth OutcomesaAnnals of the New York Academy of Sciences, 1994
- Relationship of psychiatric illness to childbearing status: a hospital-based epidemiologic studyJournal of Affective Disorders, 1993
- Self-reported depression and negative pregnancy outcomesJournal of Clinical Epidemiology, 1992
- Predictive value of minor anomalies. I. Association with major malformationsThe Journal of Pediatrics, 1987
- Neonatal convulsions caused by withdrawal from maternal clomipramine.BMJ, 1982
- WITHDRAWAL SYMPTOMS IN NEONATES ASSOCIATED WITH MATERNAL ANTIDEPRESSANT THERAPYThe Lancet, 1973